Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 1, 2011, Pages 5-12

  Camilleri, Michael ^a   Bharucha, Adil E ^a   Farrugia, Gianrico ^a  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

Author keywords

Diabetes; Gastroparesis; Pharmacotherapy; Treatment

Indexed keywords

ANTIEMETIC AGENT; ATI 7505; AZITHROMYCIN; BOTULINUM TOXIN; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; GHRELIN; GSK 962040; METOCLOPRAMIDE; PROKINETIC AGENT; PRUCALOPRIDE; RQ 00201894; SEROTONIN AGONIST; TRAMADOL; TZP 101; UNCLASSIFIED DRUG; VELUSETRAG;

AKATHISIA; CLINICAL TRIAL; DIABETES MELLITUS; DYSKINESIA; DYSTONIA; DYSTONIC DISORDER; ELECTROSTIMULATION; GASTROSTOMY; GLYCEMIC CONTROL; HUMAN; JEJUNOSTOMY; NUTRITION; PARKINSONISM; PATHOPHYSIOLOGY; PSEUDOPARKINSONISM; REVIEW; STEM CELL TRANSPLANTATION; STOMACH PARESIS; TARDIVE DYSKINESIA;

DIABETES COMPLICATIONS; GASTROPARESIS; HUMANS;

EID: 78650254200     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.09.022     Document Type: Review

References (0)